Extending the application of a magnetic PEG three-part drug release device on a graphene substrate for the removal of Gram-positive and Gram-negative bacteria and cancerous and pathologic cells

Autor: Ramezani Farani M, Khadive Parsi P, Riazi Gh, Shafiee Ardestani M, Saligheh Rad H

Publikováno v: Drug Design, Development and Therapy, Vol Volume 13, Pp 1581-1591 (2019)

M Ramezani Farani,1 P Khadive Parsi,1 Gh Riazi,2 M Shafiee Ardestani,3 H Saligeh Rad4,5 1School of Chemical Engineering, University College of Engineering, University of Tehran, Tehran 4563-11155, Iran; 2Institute of Biophysics and Biochemistry, Univ

Externí odkaz: https://doaj.org/article/1447c843db1149e78c2b59d0af95cea5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Protection of Beta Boswellic Acid against Streptozotocin-induced Alzheimer's Model by Reduction of Tau Phosphorylation Level and Enhancement of Reelin Expression.

Autor: Shasaltaneh MD; Department of Biology, Faculty of Science, University of Zanjan, Zanjan, Iran., Naghdi N; Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran., Ramezani S; Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.; University of Sistan and Baluchestan, Zahedan, Iran., Alizadeh L; Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran., Riazi GH; Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Publikováno v: Planta medica [Planta Med] 2022 Apr; Vol. 88 (5), pp. 367-379. Date of Electronic Publication: 2021 Jun 11.

The brain 3β-HSD up-regulation in response to deteriorating effects of background emotional stress: an animal model of multiple sclerosis.

Autor: Meknatkhah S; Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran., Mousavi MS; Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran., Sharif Dashti P; Department of Chemical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran., Azizzadeh Pormehr L; Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran., Riazi GH; Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran. ghriazi@ut.ac.ir.

Publikováno v: Metabolic brain disease [Metab Brain Dis] 2021 Aug; Vol. 36 (6), pp. 1253-1258. Date of Electronic Publication: 2021 Mar 15.